Tonix Pharmaceuticals Holding (TNXP) Non Operating Income (2023 - 2025)
Historic Non Operating Income for Tonix Pharmaceuticals Holding (TNXP) over the last 3 years, with Q3 2025 value amounting to -$1.2 million.
- Tonix Pharmaceuticals Holding's Non Operating Income fell 252727.27% to -$1.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$4.2 million, marking a year-over-year decrease of 24012.94%. This contributed to the annual value of -$2.1 million for FY2024, which is 22073.17% down from last year.
- Tonix Pharmaceuticals Holding's Non Operating Income amounted to -$1.2 million in Q3 2025, which was down 252727.27% from -$2.0 million recorded in Q2 2025.
- Over the past 5 years, Tonix Pharmaceuticals Holding's Non Operating Income peaked at $394000.0 during Q1 2025, and registered a low of -$2.0 million during Q2 2025.
- Moreover, its 3-year median value for Non Operating Income was -$593000.0 (2024), whereas its average is -$585333.3.
- Per our database at Business Quant, Tonix Pharmaceuticals Holding's Non Operating Income crashed by 2134285.71% in 2024 and then skyrocketed by 16644.18% in 2025.
- Tonix Pharmaceuticals Holding's Non Operating Income (Quarter) stood at $7000.0 in 2023, then plummeted by 21342.86% to -$1.5 million in 2024, then increased by 22.26% to -$1.2 million in 2025.
- Its last three reported values are -$1.2 million in Q3 2025, -$2.0 million for Q2 2025, and $394000.0 during Q1 2025.